Authors:
VANDEL P
BONIN B
BERTSCHY G
BAUMANN P
BOUQUET S
VANDEL S
SECHTER D
BIZOUARD P
Citation: P. Vandel et al., OBSERVATIONS OF THE INTERACTION BETWEEN TRICYCLIC ANTIDEPRESSANTS ANDFLUVOXAMINE IN POOR METABOLIZERS OF DEXTROMETHORPHAN AND MEPHENYTOIN, Therapie, 52(1), 1997, pp. 74-76
Authors:
VANDEL P
BONIN B
VANDEL S
SECHTER D
BIZOUARD P
Citation: P. Vandel et al., CYP 2D6 PM PHENOTYPE HYPOTHESIS OF ANTIDEPRESSANT EXTRAPYRAMIDAL SIDE-EFFECTS, Medical hypotheses, 47(6), 1996, pp. 439-442
Authors:
RAZAVI D
ALLILAIRE JF
SMITH M
SALIMPOUR A
VERRA M
DESCLAUX B
SALTEL P
PIOLLET I
GAUVAINPIQUARD A
TRICHARD C
CORDIER B
FRESCO R
GUILLIBERT E
SECHTER D
ORTH JP
BOUHASSIRA M
MESTERS P
BLIN P
Citation: D. Razavi et al., THE EFFECT OF FLUOXETINE ON ANXIETY AND DEPRESSION SYMPTOMS IN CANCER-PATIENTS, Acta psychiatrica Scandinavica, 94(3), 1996, pp. 205-210
Authors:
VANDEL S
BERTSCHY G
BAUMANN P
BOUQUET S
BONIN B
FRANCOIS T
SECHTER D
BIZOUARD P
Citation: S. Vandel et al., FLUVOXAMINE AND FLUOXETINE - INTERACTION STUDIES WITH AMITRIPTYLINE, CLOMIPRAMINE AND NEUROLEPTICS IN PHENOTYPED PATIENTS, Pharmacological research, 31(6), 1995, pp. 347-353
Authors:
LEROUX JM
ELIA E
JACQUET M
POMMERY J
LEVRON JC
BOUHOURS P
ERB F
SECHTER D
Citation: Jm. Leroux et al., CORRELATION OF CLINICAL-RESPONSE (PANSS) AND PLASMA-LEVELS OF HALOPERIDOL AND REDUCED HALOPERIDOL IN SCHIZOPHRENIA, Progress in neuro-psychopharmacology & biological psychiatry, 18(2), 1994, pp. 347-353